Open AccessThis article is
- freely available
Herpes Virus Amplicon Vectors
Department of Biochemistry and Biophysics, University of Rochester, Rochester, NY 14642, USA
Center for Neural Development and Disease, University of Rochester, Rochester, NY 14642, USA
School of Medicine and Dentistry, University of Rochester, Rochester, NY 14642, USA
Department of Neurology, University of Rochester, Rochester, NY 14642, USA
Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA
* Author to whom correspondence should be addressed.
Received: 30 September 2009 / Revised: 26 October 2009 / Accepted: 29 October 2009 / Published: 29 October 2009
Abstract Since its emergence onto the gene therapy scene nearly 25 years ago, the replication-defective Herpes Simplex Virus Type-1 (HSV-1) amplicon has gained significance as a versatile gene transfer platform due to its extensive transgene capacity, widespread cellular tropism, minimal immunogenicity, and its amenability to genetic manipulation. Herein, we detail the recent advances made with respect to the design of the HSV amplicon, its numerous in vitro and in vivo applications, and the current impediments this virus-based gene transfer platform faces as it navigates a challenging path towards future clinical testing.
This is an open access article distributed under the
Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Share & Cite This Article
MDPI and ACS Style
De Silva, S.; Bowers, W.J. Herpes Virus Amplicon Vectors. Viruses 2009, 1, 594-629.
View more citation formats
De Silva S, Bowers WJ. Herpes Virus Amplicon Vectors. Viruses. 2009; 1(3):594-629.
De Silva, Suresh; Bowers, William J. 2009. "Herpes Virus Amplicon Vectors." Viruses 1, no. 3: 594-629.
Notes: Multiple requests from the same IP address are counted as one view.
For more information on the journal, click here
[Return to top]